A Sovereign-Wealth Fund to Keep America's Technological Edge
Other countries have used sovereign-wealth funds to great national advantage. Norway's Government Pension Fund Global is the premier example. It sets the standard for performance and transparency, delivering consistent returns while adhering to strict ethical guidelines. The Government of Singapore Investment Corp. generates outsize influence for the small nation. Oil-rich states leverage their wealth strategically with funds such as Abu Dhabi's Mubadala investment fund, which aims to position the United Arab Emirates as a global AI hub.
Critics rightly point out that an American sovereign-wealth fund must be free of political interference and focused on commercial national research and defense priorities. But other nations' examples prove this is possible. There are also concerns about forming a fund when the U.S. is running budget deficits. The benefits far outweigh the risk. America needs this fund now more than ever.
Both geopolitics and innovation shape the economy. It isn't enough to hope we maintain tech leadership through our financial dominance, banking leadership, private venture capital and intermittent government interventions. American firms have to grapple with difficult market distortions thanks to Chinese state investment, which places U.S. tech companies at a disadvantage. Beijing has formed various state-backed venture funds to invest in AI, quantum research and semiconductor manufacturing. These investments foster domestic innovation and advance strategic sectors. China's National Venture Capital Guidance Fund channels tens of billions of dollars of central, provincial and private capital into key technologies, aligning investments explicitly with industrial strategy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Does JOST Werke SE (ETR:JST) Create Value For Shareholders?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. By way of learning-by-doing, we'll look at ROE to gain a better understanding of JOST Werke SE (ETR:JST). ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Simply put, it is used to assess the profitability of a company in relation to its equity capital. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Is ROE Calculated? The formula for return on equity is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for JOST Werke is: 11% = €46m ÷ €406m (Based on the trailing twelve months to March 2025). The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every €1 worth of equity, the company was able to earn €0.11 in profit. See our latest analysis for JOST Werke Does JOST Werke Have A Good Return On Equity? By comparing a company's ROE with its industry average, we can get a quick measure of how good it is. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. If you look at the image below, you can see JOST Werke has a similar ROE to the average in the Machinery industry classification (10%). That isn't amazing, but it is respectable. Even if the ROE is respectable when compared to the industry, its worth checking if the firm's ROE is being aided by high debt levels. If a company takes on too much debt, it is at higher risk of defaulting on interest payments. Our risks dashboardshould have the 3 risks we have identified for JOST Werke. Why You Should Consider Debt When Looking At ROE Companies usually need to invest money to grow their profits. That cash can come from issuing shares, retained earnings, or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the debt required for growth will boost returns, but will not impact the shareholders' equity. In this manner the use of debt will boost ROE, even though the core economics of the business stay the same. JOST Werke's Debt And Its 11% ROE JOST Werke clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 1.52. With a fairly low ROE, and significant use of debt, it's hard to get excited about this business at the moment. Debt does bring extra risk, so it's only really worthwhile when a company generates some decent returns from it. Summary Return on equity is one way we can compare its business quality of different companies. A company that can achieve a high return on equity without debt could be considered a high quality business. If two companies have around the same level of debt to equity, and one has a higher ROE, I'd generally prefer the one with higher ROE. Having said that, while ROE is a useful indicator of business quality, you'll have to look at a whole range of factors to determine the right price to buy a stock. It is important to consider other factors, such as future profit growth -- and how much investment is required going forward. So I think it may be worth checking this free report on analyst forecasts for the company. If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
UK Penny Stock Highlights: Diaceutics And 2 Compelling Options
The UK market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. For investors exploring opportunities beyond established names, penny stocks—typically smaller or newer companies—can offer intriguing prospects despite their somewhat outdated moniker. These stocks may present surprising value and potential stability when backed by solid financial health; in this article, we examine three such penny stocks that could offer compelling investment opportunities. Top 10 Penny Stocks In The United Kingdom Name Share Price Market Cap Financial Health Rating FRP Advisory Group (AIM:FRP) £1.215 £301.38M ★★★★★☆ Foresight Group Holdings (LSE:FSG) £4.535 £508.81M ★★★★★★ Warpaint London (AIM:W7L) £4.30 £347.39M ★★★★★★ Van Elle Holdings (AIM:VANL) £0.395 £42.74M ★★★★★★ System1 Group (AIM:SYS1) £4.25 £53.93M ★★★★★★ LSL Property Services (LSE:LSL) £3.04 £313.01M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.245 £198.48M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.82 £11.29M ★★★★★★ Braemar (LSE:BMS) £2.26 £69.82M ★★★★★★ ME Group International (LSE:MEGP) £2.17 £819.53M ★★★★★★ Click here to see the full list of 296 stocks from our UK Penny Stocks screener. Let's explore several standout options from the results in the screener. Diaceutics Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Diaceutics PLC is a diagnostic commercialization company that offers data, data analytics, and implementation services to pharmaceutical and biotech companies, with a market cap of £108.64 million. Operations: The company generates revenue from its Medical Labs & Research segment, totaling £32.16 million. Market Cap: £108.64M Diaceutics PLC, with a market cap of £108.64 million and revenue of £32.16 million, is navigating the challenges typical for smaller stocks in its sector. Despite being unprofitable, the company maintains a strong cash position with short-term assets exceeding liabilities and no debt burden. However, the board's limited experience and recent insider selling may raise concerns among investors. Analysts anticipate significant stock price appreciation, suggesting potential upside if growth forecasts materialize. The company's stable weekly volatility and absence of shareholder dilution over the past year provide some reassurance amidst its current financial struggles. Dive into the specifics of Diaceutics here with our thorough balance sheet health report. Review our growth performance report to gain insights into Diaceutics' future. Ashmore Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ashmore Group plc is a publicly owned investment manager with a market cap of £1.13 billion. Operations: Ashmore Group does not report specific revenue segments. Market Cap: £1.13B Ashmore Group plc, with a market cap of £1.13 billion, presents a mixed picture for investors interested in penny stocks. Despite being debt-free and having short-term assets significantly exceeding liabilities, the company's earnings have declined by 25.1% annually over the past five years and are forecast to decline further. Recent board changes, including Anna Sweeney's appointment as Chair of the Audit and Risk Committee, may enhance governance but do not offset concerns about negative earnings growth and significant insider selling in recent months. The dividend yield is high at 9.84%, though not well covered by earnings or cash flows. Get an in-depth perspective on Ashmore Group's performance by reading our balance sheet health report here. Examine Ashmore Group's earnings growth report to understand how analysts expect it to perform. Watches of Switzerland Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Watches of Switzerland Group PLC is a retailer specializing in luxury watches and jewelry across the United Kingdom, Europe, and the United States, with a market cap of £863.05 million. Operations: The company's revenue is derived from two main geographical segments: £785.60 million from the US and £865.90 million from the UK & Europe. Market Cap: £863.05M Watches of Switzerland Group, with a market cap of £863.05 million, offers potential for penny stock investors despite some challenges. The company reported full-year sales of £1.65 billion but experienced a decline in net income to £53.8 million due to a significant one-off loss of £57.9 million. While earnings growth was negative last year, the company has demonstrated consistent profit growth over five years and forecasts suggest earnings could grow by 20.94% annually moving forward. Its debt levels are well managed, with operating cash flow covering 95.3% of its debt, though short-term assets fall slightly short in covering long-term liabilities. Navigate through the intricacies of Watches of Switzerland Group with our comprehensive balance sheet health report here. Evaluate Watches of Switzerland Group's prospects by accessing our earnings growth report. Seize The Opportunity Jump into our full catalog of 296 UK Penny Stocks here. Seeking Other Investments? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 26 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:DXRX LSE:ASHM and LSE:WOSG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Boston Globe
13 minutes ago
- Boston Globe
New Hampshire is expanding school choice. Will Massachusetts follow?
Advertisement This surge in school choice is part of a broader national trend. Enrollment in such programs has more than doubled since 2020 — from roughly 540,000 to more than Massachusetts, home to some of the nation's strongest private, parochial, charter, and vocational-technical schools, is increasingly being left behind, politically unwilling and legally constrained from offering families access to private options. The catalyst for this wave of private options was the US Supreme Court's 2020 decision in Espinoza v. Montana Department of Revenue. The court Advertisement Her story resonated nationwide, particularly during the pandemic. The move to online learning by public schools, union resistance to returning students to the classroom, and a seeming disregard for students' mental health and learning loss drove many families toward private and homeschool options. Even in Massachusetts, Massachusetts may remain among the top-performing states nationally, but that status masks a troubling decline. On the National Assessment of Educational Progress (the nation's report card), average eighth-grade The pandemic and student distraction due to cellphones are partially to blame, but the decline is Clearly there is a hunger for options other than traditional public school. Advertisement New Hampshire's latest choice expansion is relevant to Massachusetts because, in addition to the two states' cultural and demographic similarities, they post nearly identical academic performance. On the 2024 NAEP, New Hampshire eighth-graders scored averages of 280 in As student performance declines, Massachusetts lawmakers remain committed to a top-down, monopolistic education system. They refuse to consider private school choice, hiding behind 19th-century anti-Catholic amendments in the state constitution that prohibit public funds from flowing to religious schools, even indirectly. At the same time, lawmakers have stood by as the pillars of the Commonwealth's landmark 1993 education reforms — strong academic standards, accountability through testing, and choice through charter schools — have steadily eroded. New Hampshire is taking a more pragmatic approach: It is steadily expanding school choice with thoughtful fiscal safeguards and a clear focus on helping the students most in need. As a result, many more New Hampshire parents will now be able to narrow class- and race-based achievement gaps — whether through public or private schools, the small learning groups called The recently passed 'One Big Beautiful Bill,' President Trump's massive tax and spending plan, enacts the first national school choice program, offering scholarships funded through tax credits to all but the wealthiest families. Starting in 2027, taxpayers nationwide will be able to redirect up to $1,700 in federal taxes to approved scholarship organizations. Advertisement The program could benefit many of the 120,000 families in Massachusetts paying a private school tuition, or using homeschool and microschool options, which grew enormously during the pandemic. Expanding its appeal further, the program benefits families paying for after-school supplemental learning, including tutoring. The catch? States must opt in. For now, Massachusetts officials say they are For the dozens of states with school choice programs, including New Hampshire, the pathway forward is clear: Private school choice has broad public support and expands equality of educational opportunity. What will Massachusetts do?
